missing translation for 'onlineSavingsMsg'
Learn More

Epredia™ Lab Vision™ CEA (Carcinoembryonic Antigen)/CD66e Ab-3 Mouse Monoclonal Antibody, 200μg/mL, biotinylated, BSA and azide

Ensure accurate, reproducible results in immunohistochemistry, western blotting, immunofluorescence and immunoprecipitation experiments.

Brand:  Epredia™ MS-613-B1

 View more versions of this product

Product Code. 12691777

This item is currently unavailable or has been discontinued.
View the product page for possible alternatives.
View alternative products »

This item is not returnable. View return policy

Description

Description

Host Species: Mouse

Clone: COL-1

Isotype: IgG2a/κ

Species Reactivity: Human. Does not react with rat. Others not known.

Immunogen: Human colon carcinoma extract

Molecular Weight: 180 kDa

Positive Control: LS174T cells, Colon CA

Cellular Localization: Cytoplasmic and luminal membrane

Recommended for:

  • Immunohistochemistry (Formalin/paraffin)
  • Western Blotting
  • Immunofluorescence
  • Immunoprecipitation (Native and denatured)

Note:

USA: RUO; Int'l: RUO

TRUSTED_SUSTAINABILITY
Specifications

Specifications

CEA (Carcinoembryonic Antigen)/CD66e Ab-3
Monoclonal
200μg/mL
Mouse
500 μL
Oncogenesis
Human
IgG2a κ
Immunofluorescence, Immunohistochemistry (Paraffin), Immunoprecipitation, Western Blot
COL-1
Biotin
Human colon carcinoma extract
RUO
Primary
Concentrated
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.